Invesco Pharmaceuticals ETF
PJP
PJP
80 hedge funds and large institutions have $68.9M invested in Invesco Pharmaceuticals ETF in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
Holders
80
Holding in Top 10
–
Calls
$221K
Puts
–
Top Buyers
| 1 | +$8.29M | |
| 2 | +$1.41M | |
| 3 | +$1.12M | |
| 4 |
Morgan Stanley
New York
|
+$797K |
| 5 |
Goldman Sachs
New York
|
+$675K |
Top Sellers
| 1 | -$239K | |
| 2 | -$228K | |
| 3 | -$157K | |
| 4 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$151K |
| 5 |
BCM
BTR Capital Management
Oakland,
California
|
-$146K |